1. Home
  2. BEEP vs ARMP Comparison

BEEP vs ARMP Comparison

Compare BEEP & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile Infrastructure Corporation

BEEP

Mobile Infrastructure Corporation

N/A

Current Price

$2.45

Market Cap

111.2M

Sector

Finance

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$10.87

Market Cap

296.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BEEP
ARMP
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
296.7M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BEEP
ARMP
Price
$2.45
$10.87
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.50
$15.00
AVG Volume (30 Days)
31.3K
42.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.40
EPS
N/A
N/A
Revenue
$35,075,000.00
N/A
Revenue This Year
$4.62
N/A
Revenue Next Year
$21.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$0.90
52 Week High
$4.67
$13.75

Technical Indicators

Market Signals
Indicator
BEEP
ARMP
Relative Strength Index (RSI) 29.92 58.88
Support Level N/A $5.14
Resistance Level $3.24 $12.23
Average True Range (ATR) 0.21 1.14
MACD -0.07 -0.03
Stochastic Oscillator 14.12 65.33

Price Performance

Historical Comparison
BEEP
ARMP

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provide access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: